“…No firm conclusions can thus be drawn as to their reliability, validity and prognostic value. The findings of this study are, however, consistent with the available literature on FGID as to the high comorbidity of the mood and anxiety disorders [13, 14, 15, 16, 17], the presence of other, non-gastrointestinal-related, medically unexplained symptoms [49, 50, 51]and the low pain threshold in bodily sites beyond the symptom-related region of the gastrointestinal tract [52]. They are also consistent with the growing awareness of the importance of subclinical affective symptomatology [53, 54], particularly in the medical setting [22].…”